DAVID BEARSS

Profile

First Name

: DAVID

Middle Name

:

Last Name

: BEARSS

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

TOLERO PHARMACEUTICALS, INC.

DALLIN ANDERSON, DAVID BEARSS, PH.D.

DIRECTOR, PROMOTER, EXECUTIVE OFFICER

SALARIUS PHARMACEUTICALS, LLC

DAVID ARTHUR, DAVID J. ARTHUR, JONATHAN NORTHRUP, SUNIL SHARMA

EXECUTIVE OFFICER, DIRECTOR, PROMOTER

HALIA THERAPEUTICS, INC.

JARED BEARSS, JEFFREY BURTON, JOHN S.K. KAUWE, MIKE MCCULLAR, TODD PEDERSEN, GARY B. SABIN, JIM SAVAS

DIRECTOR

SCIENTIA VASCULAR, LLC

DE LYLE BLOOMQUIST, NATHAN DAU, HUY M. DO, JEFFREY GLADDEN, JERRY HENLEY, JOHN LIPPERT, STACY LIPPERT, JANET LOWE, LARRY MYRES, RICK RANDALL, MAHENDRA SHAH, JOSEPH SILETTO

EXECUTIVE OFFICER, DIRECTOR

ROBERT BAXTER, ELAZER EDELMAN, ROBERT LANGER, RICHARD LINDER, ERIC PEARSON, DAVID SAMPSON, MARK STAUTBERG, JAMES TOBIN

DIRECTOR

CANARY SPEECH INC.

JEFF ADAMS, JAMES ENGEBRETSEN, PETER KAANAPU, RICK KREIFELDT, JEREMY MCFADDEN, HENRY O-CONNELL, TRENT PERRY, WILLIAM O. PERRY, WILLIAM O PERRY IV, RYAN TIDWALL, RYAN TIDWELL, IVONNE VALDES

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2025-07-01

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-03-31

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-12-16

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-05-12

D

BIOTECHNOLOGY

NO REVENUES

Debt

2021-06-30

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2021-05-26

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-02-03

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-10-09

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-03-22

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2013-03-21

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-04-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2012-07-17